Singapore Participates in International Remdesivir Drug Trial
08 Apr 2020

NCID, NUH, and SGH will be taking part in an international phase three trial on the use of Remdisvir on patients diagnosed with COVID-19. It was initially used to treat ebola. Requirement for trials started in mid-February. NCID said that it failed as an ebola drug but said that it was found to be the most effective drug so far in the laboratories.

Find out more here: CNA Singapore Tonight